S00–T88: Injury, Poisoning and Certain Other Consequences of External Causes
Chapter 19 of ICD-10-CM 2027, 54,325 codes in 24 blocks.
Advertisements
Codes in this chapter
All codesBillable only41,187 results
- T44.1X6DUnderdosing of other parasympathomimetics [cholinergics], subsequent encounter
- T44.1X6SUnderdosing of other parasympathomimetics [cholinergics], sequela
- T44.2X1APoisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
- T44.2X1DPoisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter
- T44.2X1SPoisoning by ganglionic blocking drugs, accidental (unintentional), sequela
- T44.2X2APoisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
- T44.2X2DPoisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter
- T44.2X2SPoisoning by ganglionic blocking drugs, intentional self-harm, sequela
- T44.2X3APoisoning by ganglionic blocking drugs, assault, initial encounter
- T44.2X3DPoisoning by ganglionic blocking drugs, assault, subsequent encounter
- T44.2X3SPoisoning by ganglionic blocking drugs, assault, sequela
- T44.2X4APoisoning by ganglionic blocking drugs, undetermined, initial encounter
- T44.2X4DPoisoning by ganglionic blocking drugs, undetermined, subsequent encounter
- T44.2X4SPoisoning by ganglionic blocking drugs, undetermined, sequela
- T44.2X5AAdverse effect of ganglionic blocking drugs, initial encounter
- T44.2X5DAdverse effect of ganglionic blocking drugs, subsequent encounter
- T44.2X5SAdverse effect of ganglionic blocking drugs, sequela
- T44.2X6AUnderdosing of ganglionic blocking drugs, initial encounter
- T44.2X6DUnderdosing of ganglionic blocking drugs, subsequent encounter
- T44.2X6SUnderdosing of ganglionic blocking drugs, sequela
- T44.3X1APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
- T44.3X1DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter
- T44.3X1SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela
- T44.3X2APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
- T44.3X2DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter
- T44.3X2SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela
- T44.3X3APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
- T44.3X3DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
- T44.3X3SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela
- T44.3X4APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
- T44.3X4DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
- T44.3X4SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
- T44.3X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
- T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.3X6AUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
- T44.3X6DUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X6SUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.4X1APoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
- T44.4X1DPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
- T44.4X1SPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
- T44.4X2APoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
- T44.4X2DPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
- T44.4X2SPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
- T44.4X3APoisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
- T44.4X3DPoisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
- T44.4X3SPoisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
- T44.4X4APoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
- T44.4X4DPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
- T44.4X4SPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela